Email   Print
Projects > NIATx 200

NIATx 200

NIATx 200 is an 18-month clinical trial designed to evaluate the cost effectiveness of field-tested process improvement strategies for addiction treatment providers.

The Study

Five states—Massachusetts, Michigan, New York, Oregon, and Washington—will recruit 40 providers to take part in this study.

Each of the 200 agencies are randomly assigned to one of four study groups, each with a different combination of services. The study aims to help determine which combinations of collaborative services produce the greatest improvement for the economic investment.

Providers in the NIATx 200 study commit to an 18-month engagement in which they participate in the services provided to their randomly assigned study group. At the same time, they test promising practices, collect and report their data, and provide staff responses to questionnaires and surveys.

The participating treatment providers, with support from their single state agency (SSA), will focus their efforts in three areas—providing same day therapeutic services, increasing client participation, and transitioning clients between levels of care.

The Partners

NIATx 200 is a partnership with the National Institute on Drug Abuse (NIDA) and the Network for the Improvement of Addiction Treatment (NIATx).

NIDA supports over 85 percent of the world’s research on the health aspects of drug abuse and addiction and sponsors programs to better understand the causes and consequences of drug abuse, to develop improved treatments and preventions, and to increase awareness among the public and health professionals to reduce the toll of this disease on affected individuals and their families and friends.